Structure |
Chemical Name |
CAS |
MF |
![Cefoxitin iMpurity F (S-Methoxy cefoxitin)](/) |
Cefoxitin iMpurity F (S-Methoxy cefoxitin) |
|
|
![Clopidogrel IMpurity 1](/CAS/20150408/GIF/CB52706747.gif) |
Clopidogrel IMpurity 1 |
|
C15H14ClNO2S |
![LincoMycin iMpurity A](/) |
LincoMycin iMpurity A |
|
|
![Posaconazole iMpurity 1](/) |
Posaconazole iMpurity 1 |
|
|
![Riociguat IMpurtiy](/) |
Riociguat IMpurtiy |
2920299-23-4 |
|
![TelMisartan IMpurity E](/) |
TelMisartan IMpurity E |
|
|
![IverMectin B1 Mono-sugar Derivative](/CAS/20211123/GIF/71837-27-9.gif) |
IverMectin B1 Mono-sugar Derivative |
71837-27-9 |
C41H62O11 |
![Desethyl Acetate (E)-CefuroxiMe Axetil](/CAS/20200515/GIF/97232-97-8.gif) |
Desethyl Acetate (E)-CefuroxiMe Axetil |
97232-97-8 |
C16H16N4O8S |
![N-メチル-3-フェニルプロピルアミン塩酸塩](/CAS/20150408/GIF/30684-07-2.gif) |
N-メチル-3-フェニルプロピルアミン塩酸塩 |
30684-07-2 |
C10H16ClN |
![1-[2-[(2,6-diMethylphenyl)thio]phenyl]- Piperazine](/CAS/20150408/GIF/508233-76-9.gif) |
1-[2-[(2,6-diMethylphenyl)thio]phenyl]- Piperazine |
508233-76-9 |
C18H22N2S |
![1-NaphthaleneMethanaMine, α-Methyl-N-[[3-(trifluoroMethyl)phenyl]Methyl]-, (αR)-](/CAS/20180808/GIF/1229512-52-0.gif) |
1-NaphthaleneMethanaMine, α-Methyl-N-[[3-(trifluoroMethyl)phenyl]Methyl]-, (αR)- |
1229512-52-0 |
C20H18F3N |
![Benzoic acid, 2-[[[[(5S)-2-oxo-3-[4-(3-oxo-4-Morpholinyl)phenyl]-5-oxazolidinyl]Methyl]aMino]carbonyl]-](/CAS/20150408/GIF/1365267-37-3.gif) |
Benzoic acid, 2-[[[[(5S)-2-oxo-3-[4-(3-oxo-4-Morpholinyl)phenyl]-5-oxazolidinyl]Methyl]aMino]carbonyl]- |
1365267-37-3 |
C22H21N3O7 |
![NSC 609249](/CAS/20150408/GIF/51012-67-0.gif) |
NSC 609249 |
51012-67-0 |
C12H20ClNO2 |
![2-エトキシ-5-[(4-メチルピペラジノ)スルホニル]ベンズアルデヒド](/CAS/20150408/GIF/332374-42-2.gif) |
2-エトキシ-5-[(4-メチルピペラジノ)スルホニル]ベンズアルデヒド |
332374-42-2 |
C14H20N2O4S |
![ApovincaMinic Acid Ethyl Ester N-Oxide](/CAS/20180808/GIF/109741-24-4.gif) |
ApovincaMinic Acid Ethyl Ester N-Oxide |
109741-24-4 |
C22H26N2O3 |
![(2R,4S)-2-メチル-4-アミノ-5-(4-ビフェニリル)ペンタン酸エチル](/CAS/20150408/GIF/752174-62-2.gif) |
(2R,4S)-2-メチル-4-アミノ-5-(4-ビフェニリル)ペンタン酸エチル |
752174-62-2 |
C20H25NO2 |
![EMpagliflozin iMpurity 12](/) |
EMpagliflozin iMpurity 12 |
|
|
![(2S,4R)-Teneligliptin](/CAS/20150408/GIF/1404559-15-4.gif) |
(2S,4R)-Teneligliptin |
1404559-15-4 |
C22H30N6OS |
![Daclatasvir Impurity](/CAS/20180808/GIF/1417333-83-5.gif) |
Daclatasvir Impurity |
1417333-83-5 |
C40H50N8O6 |
![1-[2-[(3,4-diMethylphenyl)thio]phenyl]- Piperazine](/CAS/20150408/GIF/1293489-74-3.gif) |
1-[2-[(3,4-diMethylphenyl)thio]phenyl]- Piperazine |
1293489-74-3 |
C18H22N2S |
![carfilzoMib iMpurity -A](/) |
carfilzoMib iMpurity -A |
|
|
![(3S,4R)-1-(4-fluorophenyl)-3-((S)-3-(4-fluorophenyl)-3-hydroxypropyl)-4-(4-hydroxyphenyl)azetidin-2-one](/CAS/20150408/GIF/CB52735587.gif) |
(3S,4R)-1-(4-fluorophenyl)-3-((S)-3-(4-fluorophenyl)-3-hydroxypropyl)-4-(4-hydroxyphenyl)azetidin-2-one |
1593543-00-0 |
C24H21F2NO3 |
![ethyl N-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)Methyl)-N-pentanoyl-L-valinate](/CAS/20150408/GIF/1111177-30-0.gif) |
ethyl N-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)Methyl)-N-pentanoyl-L-valinate |
1111177-30-0 |
C26H33N5O3 |
![Rosuvastatin EP impurity A](/CAS/20180808/GIF/1714147-50-8.gif) |
Rosuvastatin EP impurity A |
1714147-50-8 |
C25H34FN3NaO7S* |
![Doxorubicin Impurity 6](/CAS/20240320/GIF/69429-21-6.gif) |
Doxorubicin Impurity 6 |
69429-21-6 |
C26H27NO11 |
![Etoricoxib Impurity 11](/CAS/20180808/GIF/202409-31-2.gif) |
Etoricoxib Impurity 11 |
202409-31-2 |
C17H13ClN2O2S |
![Levofloxacin Tetrafluoro Impurity 1](/CAS/20210111/GIF/110548-02-2.gif) |
Levofloxacin Tetrafluoro Impurity 1 |
110548-02-2 |
C15H15F4NO4 |
![Penicillin F Potassium Salt](/CAS/20211123/GIF/97299-13-3.gif) |
Penicillin F Potassium Salt |
97299-13-3 |
C14H21KN2O4S |
![Olaparib Impurity 31](/CAS/20180703/GIF/458535-34-7.gif) |
Olaparib Impurity 31 |
458535-34-7 |
C12H18N2O2 |
![Macitentan impurity A](/CAS/20180808/GIF/441798-25-0.gif) |
Macitentan impurity A |
441798-25-0 |
C17H16Br2N6O4S |
![4-(3,4-DICHLOROPHENYL)-3,4-DIHYDRO-2H-NAPHTHALEN-1-ONE OXIME](/StructureFile/ChemBookStructure6/GIF/CB5293238.gif) |
4-(3,4-DICHLOROPHENYL)-3,4-DIHYDRO-2H-NAPHTHALEN-1-ONE OXIME |
152642-35-8 |
C16H13Cl2NO |
![Linagliptin Impurity C](/) |
Linagliptin Impurity C |
|
|
![Parecoxib Impurity B](/) |
Parecoxib Impurity B |
|
|
![Vildagliptin impurity E](/) |
Vildagliptin impurity E |
|
|
![3-propylisobenzofuran-1(3H)-one](/CAS/20180703/GIF/72424-08-9.gif) |
3-propylisobenzofuran-1(3H)-one |
72424-08-9 |
C11H12O2 |
![(R)-4-fluoro-2-((3-methyl-6-(3-((1-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)amino)piperidin-1-yl)-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzonitrile](/CAS/20180703/GIF/CB53042208.gif) |
(R)-4-fluoro-2-((3-methyl-6-(3-((1-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)amino)piperidin-1-yl)-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzonitrile |
|
C23H24FN7O4 |
![Empagliflozin impurity B](/) |
Empagliflozin impurity B |
|
|
![Varenicline Impurity 1](/) |
Varenicline Impurity 1 |
|
|
![Voriconazole Impurity 6](/) |
Voriconazole Impurity 6 |
|
|
![Caspofungin impurity 1](/) |
Caspofungin impurity 1 |
|
|
![Cabozantinib impurity D](/) |
Cabozantinib impurity D |
|
|
![Neratinib Impurity 3](/) |
Neratinib Impurity 3 |
|
|
![Ranitidine Impurity D](/CAS/20200331/GIF/CB53127408.gif) |
Ranitidine Impurity D |
|
C13H22N4O3S |
![Metoprolol IMpurity 5](/CAS/20200331/GIF/CB53127589.gif) |
Metoprolol IMpurity 5 |
|
C15H25NO3 |
![Mirabegron Impurity 2](/) |
Mirabegron Impurity 2 |
|
|
![Pemetrexed Impurity 1](/CAS/20210111/GIF/1644287-26-2.gif) |
Pemetrexed Impurity 1 |
1644287-26-2 |
C20H21N5O8 |
![Plerixafor Impurity B](/) |
Plerixafor Impurity B |
|
|
![Tolvaptan impurity3](/) |
Tolvaptan impurity3 |
|
|
![Vonoprazan Impurity 7](/) |
Vonoprazan Impurity 7 |
|
|
![Cefazolin impurity F](/) |
Cefazolin impurity F |
|
|
![Ritodrine BP Impurity D](/) |
Ritodrine BP Impurity D |
|
|
![Rivaroxaban Impurity 19](/) |
Rivaroxaban Impurity 19 |
|
|
![Topiroxostat Impurity 4](/CAS/20200611/GIF/1379342-46-7.gif) |
Topiroxostat Impurity 4 |
1379342-46-7 |
C8H8N2O3 |
![Ertapenem impurity 1](/) |
Ertapenem impurity 1 |
|
|
![(R)-2-(3-(diisopropylamino)-1-phenylpropyl)-4-(hydroxymethyl)phenyl methacrylate](/CAS/20200331/GIF/CB53129538.gif) |
(R)-2-(3-(diisopropylamino)-1-phenylpropyl)-4-(hydroxymethyl)phenyl methacrylate |
|
C26H36NO3 |
![Flomoxef Impurity 3](/) |
Flomoxef Impurity 3 |
|
|
![Ropivacaine impurity](/CAS/20210111/GIF/1105704-96-8.gif) |
Ropivacaine impurity |
1105704-96-8 |
C12H14N2O3 |
![Diquafosol Impurity 1](/CAS/20210111/GIF/26184-65-6.gif) |
Diquafosol Impurity 1 |
26184-65-6 |
C18H24N4O17P2 |
![Milnacipran Impurity 3](/CAS/20200515/GIF/1353644-50-4.gif) |
Milnacipran Impurity 3 |
1353644-50-4 |
C15H20ClNO |
![L-Glutamic acid 1-ethyl ester](/CAS/20180703/GIF/52454-78-1.gif) |
L-Glutamic acid 1-ethyl ester |
52454-78-1 |
C7H13NO4 |
![2-ヒドロキシ-2-(チオフェン-2-イル)-2-(チオフェン-3-イル)酢酸メチル](/CAS/20180703/GIF/28748-67-6.gif) |
2-ヒドロキシ-2-(チオフェン-2-イル)-2-(チオフェン-3-イル)酢酸メチル |
28748-67-6 |
C11H10O3S2 |
![N-(5-amino-2-methylphenyl)-N-(4-(pyridin-3-yl)pyrimidin-2-yl)acetamide compound with methane (1:1)](/) |
N-(5-amino-2-methylphenyl)-N-(4-(pyridin-3-yl)pyrimidin-2-yl)acetamide compound with methane (1:1) |
|
|
![N-(2-methyl-5-(methylamino)phenyl)-N-(4-(pyridin-3-yl)pyrimidin-2-yl)formamide](/CAS/20180703/GIF/CB53382313.gif) |
N-(2-methyl-5-(methylamino)phenyl)-N-(4-(pyridin-3-yl)pyrimidin-2-yl)formamide |
|
C18H17N5O |
![methyl3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin -4-yl)amino)piperidin-1-yl)-3-oxopropanoate](/CAS/20180601/GIF/1616761-01-3.gif) |
methyl3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin -4-yl)amino)piperidin-1-yl)-3-oxopropanoate |
1616761-01-3 |
C17H23N5O3 |
![Labetalol iMpurity](/) |
Labetalol iMpurity |
2731858-23-2 |
|
![ZXANKCFSGFEBQW-PFEQFJNWSA-N](/) |
ZXANKCFSGFEBQW-PFEQFJNWSA-N |
1258938-54-3 |
|
![TWEORVZIMOFLDE-MXTNKPTQSA-N](/CAS/20210305/GIF/1706671-50-2.gif) |
TWEORVZIMOFLDE-MXTNKPTQSA-N |
1706671-50-2 |
C25H31N5O9S |
![WGEFOIHAXGTXJE-RTMVWDMESA-N](/CAS/20180906/GIF/1373171-12-0.gif) |
WGEFOIHAXGTXJE-RTMVWDMESA-N |
1373171-12-0 |
C48H61NO14 |
![2-(2,4,5-トリフルオロ-3-メトキシベンゾイル)-3-エトキシアクリル酸エチルエステル](/CAS/20180906/GIF/866954-86-1.gif) |
2-(2,4,5-トリフルオロ-3-メトキシベンゾイル)-3-エトキシアクリル酸エチルエステル |
866954-86-1 |
C15H15F3O5 |
![ICOFQCJKJOISKD-HSZRJFAPSA-N](/CAS/20200515/GIF/1435768-96-9.gif) |
ICOFQCJKJOISKD-HSZRJFAPSA-N |
1435768-96-9 |
C26H35NO3 |
![Moxidectin](/CAS/20180808/GIF/119718-45-5.gif) |
Moxidectin |
119718-45-5 |
C37H53NO8 |
![GDZISNMJFAJFMR-BEQCQUFHSA-M](/CAS/20211123/GIF/2024603-92-5.gif) |
GDZISNMJFAJFMR-BEQCQUFHSA-M |
2024603-92-5 |
C58H74N2O15S |
![GJXNGCFWGJQETE-UHFFFAOYSA-N](/CAS/20210111/GIF/1796891-27-4.gif) |
GJXNGCFWGJQETE-UHFFFAOYSA-N |
1796891-27-4 |
C29H34N6O4 |
![ethyl N-[(2,5-dichlorophenyl)carbonyl]glycinate](/CAS/20180601/GIF/328283-61-0.gif) |
ethyl N-[(2,5-dichlorophenyl)carbonyl]glycinate |
328283-61-0 |
C11H11Cl2NO3 |
![Irbesartan Impurity 4](/CAS/20180601/GIF/945540-26-1.gif) |
Irbesartan Impurity 4 |
945540-26-1 |
C21H20N6O |
![BAUCJPGULMYPTE-UHFFFAOYSA-N](/CAS/20200611/GIF/2097683-67-3.gif) |
BAUCJPGULMYPTE-UHFFFAOYSA-N |
2097683-67-3 |
C24H29NO4 |
![Entecavir Impurity 6](/CAS/20180906/GIF/1354695-82-1.gif) |
Entecavir Impurity 6 |
1354695-82-1 |
C26H27N5O3 |
![Bis(L-Valine) Ester Ganciclovir TFA Salt](/CAS/20180808/GIF/130914-71-5.gif) |
Bis(L-Valine) Ester Ganciclovir TFA Salt |
130914-71-5 |
C19H31N7O6 |
![6-Chloro-6-defluoro Ciprofloxacin](/CAS/20210111/GIF/93106-58-2.gif) |
6-Chloro-6-defluoro Ciprofloxacin |
93106-58-2 |
C17H18ClN3O3 |
![2-ヒドロキシ-5-アミノ-N-(2-カルボキシ-4-アミノフェニル)安息香酸](/CAS/20180601/GIF/1797983-23-3.gif) |
2-ヒドロキシ-5-アミノ-N-(2-カルボキシ-4-アミノフェニル)安息香酸 |
1797983-23-3 |
C14H12N2O5 |
![4-[1-methoxy-2-(methylamino)ethyl]benzene-1,2-diol:hydrochloride](/CAS/20180601/GIF/74571-90-7.gif) |
4-[1-methoxy-2-(methylamino)ethyl]benzene-1,2-diol:hydrochloride |
74571-90-7 |
C10H15NO3.ClH |
![(1-methylpiperidin-4-yl)(pyridin-2-yl)methanone](/CAS/20180601/GIF/517875-04-6.gif) |
(1-methylpiperidin-4-yl)(pyridin-2-yl)methanone |
517875-04-6 |
C12H16N2O |
![2-cyano-1,3-bis(2-(((5-methyl-1H-imidazol-4-yl)methyl)thio)ethyl)guanidine](/CAS/20180703/GIF/55272-86-1.gif) |
2-cyano-1,3-bis(2-(((5-methyl-1H-imidazol-4-yl)methyl)thio)ethyl)guanidine |
55272-86-1 |
C16H24N8S2 |
![3-(4-(4-amino-5-chloro-2,3-dihydrobenzofuran-7-carboxamido)piperidin-1-yl)propyl 4-amino-5-chloro-2,3-dihydrobenzofuran-7-carboxylate](/) |
3-(4-(4-amino-5-chloro-2,3-dihydrobenzofuran-7-carboxamido)piperidin-1-yl)propyl 4-amino-5-chloro-2,3-dihydrobenzofuran-7-carboxylate |
|
|
![(1R,3R)-1-(benzo[d][1,3]dioxol-5-yl)-2-(dimethylglycyl)-2,3,4,9-tetrahydro-1H-pyrido [3,4-b]indole-3-carboxylate methyl](/CAS/20200611/GIF/2169996-11-4.gif) |
(1R,3R)-1-(benzo[d][1,3]dioxol-5-yl)-2-(dimethylglycyl)-2,3,4,9-tetrahydro-1H-pyrido [3,4-b]indole-3-carboxylate methyl |
2169996-11-4 |
C24H25N3O5 |
![Fulvestrant impurity G](/) |
Fulvestrant impurity G |
|
|
![Bendamustine Related Impurity 17](/) |
Bendamustine Related Impurity 17 |
|
|
![Bortezomib Impurity 24](/) |
Bortezomib Impurity 24 |
|
|
![Bortezomib Impurity 38](/) |
Bortezomib Impurity 38 |
|
|
![Edoxaban Impurity 27](/) |
Edoxaban Impurity 27 |
|
|
![Linagliptin Impurity 30](/CAS/20210111/GIF/2074688-81-4.gif) |
Linagliptin Impurity 30 |
2074688-81-4 |
C33H32N8O5 |
![Pantoprazole Impurity 8](/) |
Pantoprazole Impurity 8 |
|
|
![Rivaroxaban Impurity 58](/) |
Rivaroxaban Impurity 58 |
|
|
![Rivaroxaban Impurity 65](/) |
Rivaroxaban Impurity 65 |
|
|
![Sitafloxacin Impurity 4](/) |
Sitafloxacin Impurity 4 |
|
|
![Ticagrelor Related Compound 83](/) |
Ticagrelor Related Compound 83 |
|
|
![Ticagrelor Related Compound 91](/) |
Ticagrelor Related Compound 91 |
|
|
![Vonoprazan Impurity 21](/) |
Vonoprazan Impurity 21 |
|
|
![Ceftazidime Oxide Impurity](/CAS/20211123/GIF/1301254-48-7.gif) |
Ceftazidime Oxide Impurity |
1301254-48-7 |
C22H22N6O8S2 |
![N-(2,6-dimethylphenyl)-2-(4-(2-hydroxy-3-(4-methoxyphenoxy)propyl)piperazin-1-yl)acetamide](/CAS/20200331/GIF/1393717-46-8.gif) |
N-(2,6-dimethylphenyl)-2-(4-(2-hydroxy-3-(4-methoxyphenoxy)propyl)piperazin-1-yl)acetamide |
1393717-46-8 |
C24H33N3O4 |